2m 2m 2m 2m 2m 2m 2m
DEFINIUM (DFTX)
NASDAQ
$36.02-$0.21 (-0.59%)
Price as of Oct 05, 2026 7:58 PM EDT- $5.0BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
DEFINIUM (DFTX)
$36.02-$0.21 (-0.59%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 330,000 N/A | N/A N/A | 4.7M +211.97% | 1.5M +516.43% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 330,000 N/A | 0 -100.00% | 4.7M +211.97% | 1.5M +516.43% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -117.7M +80.20% | -65.3M +25.27% | -52.1M +44.11% | -36.2M +3.97% | |
Depreciation and Amortization Expense | 0 -100.00% | 527,000 -83.33% | 3.2M -0.57% | 3.2M +21.56% | |
Total Operating Expenses | 166.3M +60.04% | 103.9M +10.71% | 93.9M +41.51% | 66.3M -29.33% | |
Operating Profit | -166.3M +60.04% | -103.9M +10.71% | -93.9M +41.51% | -66.3M -29.33% | |
Interest Income | 11.0M -5.17% | 11.6M N/A | N/A N/A | N/A N/A | |
Interest Expense | -5.5M +140.12% | -2.3M +226.14% | -700,000 N/A | N/A N/A | |
Interest Income and Expense and Net | 5.5M -40.94% | 9.3M +1,425.00% | -700,000 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -17.5M +267.08% | -4.8M +155.25% | -1.9M -119.57% | 9.5M +2,912.68% | |
Income before Taxes | -166.3M +60.04% | -103.9M +10.71% | -93.9M +65.27% | -56.8M -39.70% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | -1.2M 0.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -183.8M +69.12% | -108.7M +13.52% | -95.7M +68.55% | -56.8M -38.95% | |
Net Income from Continuing Operations Applicable to Common | -183.8M +69.12% | -108.7M +13.52% | -95.7M +68.55% | -56.8M -39.70% | |
Basic EPS and Net Income | -2.06 +33.77% | -1.54 -36.89% | -2.44 +32.61% | -1.84 +700.00% | |
Diluted EPS and Net Income | -2.06 +33.77% | -1.54 -36.89% | -2.44 +32.61% | -1.84 +700.00% | |
Basic Weighted Average Shares | 89.3M +26.78% | 70.5M +79.94% | 39.2M +26.90% | 30.9M -92.49% | |
Diluted Weighted Average Shares | 89.3M +26.78% | 70.5M +79.94% | 39.2M +26.90% | 30.9M -92.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 257.8M -5.81% | 273.7M +174.55% | 99.7M -29.86% | 142.1M +6.44% | |
Short-Term Investments | 153.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 411.6M +50.36% | 273.7M +174.55% | 99.7M -29.86% | 142.1M +6.44% | |
Total Current Assets | 419.3M +48.90% | 281.6M +171.12% | 103.9M -28.88% | 146.1M +6.44% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 862,000 +40.62% | 613,000 +173.66% | 224,000 -32.33% | 331,000 N/A | |
Total Assets | 440.1M +45.66% | 302.2M +142.61% | 124.5M -26.74% | 170.0M +3.65% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 120.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 66.7M +71.69% | 38.8M +20.48% | 32.2M +80.23% | 17.9M +71.91% | |
Total Long-Term Debt | 40.6M +85.68% | 21.9M +54.67% | 14.1M N/A | N/A N/A | |
Total Long-Term Liabilities | 496,000 +1,450.00% | 32,000 0.00% | 32,000 -97.30% | 1.2M N/A | |
Total Liabilities | 107.8M +77.54% | 60.7M +30.81% | 46.4M +143.27% | 19.1M +54.61% | |
Retained Earnings | -582.7M +46.08% | -398.9M +37.45% | -290.2M +49.23% | -194.5M +41.25% | |
Total Stockholders Equity | 332.3M +37.64% | 241.4M +209.02% | 78.1M -48.23% | 150.9M -0.49% | |
Total Shares Outstanding | 98.8M +31.52% | 75.1M +82.72% | 41.1M +8.22% | 38.0M -90.99% | |
Cash Flow | |||||
Cash from Operating Activities | -131.6M +66.26% | -79.1M +22.94% | -64.4M +28.37% | -50.1M +9.42% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -151.6M N/A | N/A N/A | N/A N/A | -297,000 0.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 267.3M +5.56% | 253.2M +1,058.90% | 21.8M -63.00% | 59.1M -40.25% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -50,396.67% N/A | N/A N/A | -2,012.56% -54.64% | -4,436.86% N/A | |
Return on Assets | -49.52% -2.78% | -50.94% -21.64% | -65.01% +91.14% | -34.01% N/A | |
Return on Equity | -64.06% -5.81% | -68.01% -18.63% | -83.59% +122.66% | -37.54% N/A | |
Revenue Growth | N/A N/A | N/A N/A | 211.97% -58.95% | 516.43% N/A | |
Current Ratio | 6.29 -13.27% | 7.25 +125.04% | 3.22 -60.54% | 8.16 N/A | |
Cash Ratio | 3.87 -45.14% | 7.05 +127.89% | 3.09 -61.08% | 7.94 N/A | |
Debt-to-Equity Ratio | 0.48 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.36 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow